Researchers develop 3D bioprinting technology for eliminating cancer cells

FHS
July 12, 2023
3:19 am

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

Xyphos, Kelonia partner for immuno-oncology drug development

Share this article Xyphos will oversee the development and marketing of the products resulting from this joint research. Credit: fotohunter / Shutterstock.com. Astellas subsidiary Xyphos

February 16, 2024

PBM Regulation Bill a Good Possibility This Year, House Staffer Says

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the waning days of 2024 seems to still

January 25, 2025

Novartis is scolded by U.K. trade group for the fourth time this year over Entresto promotions

For the fourth time this year, Novartis has been reprimanded by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.